# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318154-20-000017
Filing Date
2020-02-12
Accepted
2020-02-12 17:15:19
Documents
159
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | amgn-12312019x10kq42019.htm iXBRL | 10-K | 4740655
2 | AMENDMENT TO NO. 2 TO THE ASSET PURCHASE AGREEMENT BETWEEN AMGEN AND CELGENE | a23amendmentno2toapa.htm | EX-2.3 | 21220
3 | LETTER AGREEMENT - TREATMENT OF CERTAIN PRODUCT INVENTORY | a24letteragreementv3.htm | EX-2.4 | 551630
4 | DESCRIPTION OF SECURITIES | a429descriptionofsecur.htm | EX-4.29 | 219661
5 | FORM OF GRANT OF STOCK OPTION AGREEMENT | a104grantofstockoption.htm | EX-10.4 | 253942
6 | FORM OF RESTRICTED STOCK UNIT AGREEMENT | a105restrictedstockuni.htm | EX-10.5 | 252516
7 | FORM OF PERFORMANCE UNIT AGREEMENT | a107performanceunitagr.htm | EX-10.7 | 245606
8 | DIRECTOR EQUITY INCENTIVE PROGRAM | a108-finalamendeddirec.htm | EX-10.8 | 44080
9 | FORM OF RESTRICTED STOCK UNIT AGREEMENT | a1010-amgenxdirectorrs.htm | EX-10.10 | 45224
10 | FORM OF CASH-SETTLED RESTRICTED STOCK UNIT AGREEMENT | a1011-amgenxdirectorca.htm | EX-10.11 | 42349
11 | SECOND AMENDMENT TO SUPPLEMENTAL RETIREMENT PLAN | a1014-secondamendmento.htm | EX-10.14 | 5640
12 | SECOND AMENDMENT TO NONQUALIFIED DEFERRED COMPENSATION PLAN | a1021-secondamendmentt.htm | EX-10.21 | 5655
13 | COLLABORATION AGREEMENT | a1041bridgecollaborati.htm | EX-10.41 | 664948
14 | GUARANTEE AGREEMENT | a1042guaranteeagreement.htm | EX-10.42 | 47078
15 | SUBSIDIARIES OF THE COMPANY | exhibit21significantsu.htm | EX-21 | 24304
16 | RULE 13A-14(A) CERTIFICATIONS | amgn-ex3120191231xq4.htm | EX-31 | 23760
17 | SECTION 1350 CERTIFICATIONS | amgn-ex3220191231xq4.htm | EX-32 | 10921
23 |  | a2019productsalesgraphamgn.jpg | GRAPHIC | 101128
24 |  | netherlandssecuritieslaw.jpg | GRAPHIC | 23094
25 |  | performancegraphit52019.jpg | GRAPHIC | 97474
26 |  | propertiestable2019.jpg | GRAPHIC | 102544
| Complete submission text file | 0000318154-20-000017.txt |  | 24038095

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | amgn-20191231.xsd | EX-101.SCH | 110005
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | amgn-20191231_cal.xml | EX-101.CAL | 159243
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | amgn-20191231_def.xml | EX-101.DEF | 635823
21 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | amgn-20191231_lab.xml | EX-101.LAB | 1368973
22 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | amgn-20191231_pre.xml | EX-101.PRE | 888134
129 | EXTRACTED XBRL INSTANCE DOCUMENT | amgn-12312019x10kq42019_htm.xml | XML | 4622007

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37702 | Film No.: 20605466
SIC: 2836 Biological Products, (No Diagnostic Substances)